Search

everythinglearnresearchcommunity

for

Search:↓

Certain genetic variations are linked to higher liver enzyme levels in patients treated for chronic hepatitis C with specific drugs.

34% of patients on hepatitis C treatment had reversible skin issues.

Antiviral drugs, especially daclatasvir, may be a new treatment for a rare skin disease, improving survival and reducing symptoms in mice.

Tenofovir alafenamide fumarate is effective and safer for hepatitis B, with fewer side effects than tenofovir disoproxil fumarate.

New drug uses show promise but need more research.

Repurposing existing drugs for COVID-19 shows promise but requires more research to confirm effectiveness.

Some existing drugs and natural products might work against COVID-19 by targeting the virus's main protease.

The model and estimator can predict drug exposure in kidney transplant patients well.

Some medications and supplements can cause serious side effects, including hair loss, heart rhythm problems, liver injury, and other health issues.

A patient developed hair loss after hepatitis C treatment with sofosbuvir and ribavirin.

Deucravacitinib did not significantly improve hair regrowth in alopecia areata patients.

Disitamab vedotin and gemcitabine effectively treated bladder cancer without major side effects.

Betulinic acid can help treat hepatitis C by stopping virus replication.

Daclizumab may cause psoriasis-like skin problems in multiple sclerosis patients.

Deucravacitinib helped a man regrow hair significantly.

Deferasirox combined with sorafenib reduces liver cancer risk and lessens treatment side effects.

Gemcitabine and Disitamab Vedotin effectively and safely reduced bladder cancer in a patient.

Deucravacitinib helped regrow hair and reduce plaques in a woman with discoid lupus erythematosus without side effects.

Peginterferon alpha-2a effectively treats acute hepatitis C in hemodialysed patients, despite some side effects.

Avicennia marina shows potential to treat Hepatitis C by targeting key proteins.

Tenofovir is more effective than adefovir for resistant hepatitis B, Fibroscan is good for assessing liver damage, regulatory T cells may help hepatitis C persist, and other insights into liver health and disease were found.

Deucravacitinib led to full hair regrowth in a severe alopecia areata patient.

Deucravacitinib helped a man regrow hair and improve psoriasis.

A patient with multiple sclerosis developed skin reactions after Daclizumab treatment, requiring more data on the drug's effects.

Dalpiciclib is the safest and most satisfying CDK4/6 inhibitor for advanced breast cancer patients in China.

Upadacitinib significantly improved a man's severe scalp condition when other treatments failed.

Capivasertib improves survival in certain breast cancer cases but requires careful management of side effects.

CTP-543 is generally safe for treating alopecia areata.

Upadacitinib may help treat difficult cases of systemic lupus erythematosus.